Send Inquiry

Request To Call Back

200mg Kryxana Ribociclib Tablets

Name: 200mg Kryxana Ribociclib Tablets
Brand: JAYPEE PHARMACARE
Price: 20000.0 INR
Availability: InStock

Price 20000.0 INR/ Piece

Get a Price/Quote

MOQ : 10 Pieces

200mg Kryxana Ribociclib Tablets Specification

Life Span
24 months from the date of manufacture

Dosage Form
Solid

Pacakaging (Quantity Per Box)
28 tablets per box

Indication
In combination with other therapies for the treatment of HR+/HER2- advanced or metastatic breast cancer

Salt Composition
Ribociclib 200mg

Origin of Medicine
India

Packaging Type
Box

Brand Name
Kryxana

Drug Type
Allopathic

Ingredients
Ribociclib

Physical Form
Tablets

Function
Antineoplastic agent (CDK4/6 inhibitor)

Recommended For
Adults

Dosage
200mg per tablet, as directed by a physician

Dosage Guidelines
Take once daily, as prescribed by the physician

Suitable For
Women (especially postmenopausal) with HR-positive, HER2-negative advanced or metastatic breast cancer

Quantity
28 Tablets

Storage Instructions
Store below 30C, protect from moisture and light

Colour
Light yellow to yellow

Side Effects
Fatigue, nausea, neutropenia, alopecia, leukopenia, anemia, rash

Administration Route
Oral

ATC Code
L01EF07

Warning & Precaution
Not to be used in pregnancy or lactation unless prescribed; liver and blood counts should be monitored

Therapeutic Class
Anticancer drug

Prescription Required
Yes

200mg Kryxana Ribociclib Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
500 Pieces Per Month

Delivery Time
7 Days

About 200mg Kryxana Ribociclib Tablets

Packaging Type	strip
Packaging Size	21 tablets
Dosage	200 mg
Brand Name	Kryxana
Composition	Ribociclib
Usage/Application	breast cancer
Form	Tablets
Manufacturer	Novartis India Ltd

Kryxana 200mg Tablet is an anti-cancer medicine used in the treatment of metastatic breast cancer. It helps to slow down the growth of cancer cells and eventually kills them. This way it treats the symptoms of breast cancer such as breast lumps, bloody discharge from nipples, or changes in the shape of the breast.

Kryxana 200mg Tablet may be taken with or without food and usually taken in combination with another medicine. The duration of treatment varies on the basis of your need and response to treatment. Take it in the exact dose and duration prescribed by your doctor. You may be asked for regular blood tests while taking this medication.

Common side effects of this medicine include decreased white blood cell count, nausea, fatigue, diarrhea, hair loss, vomiting, constipation, headache, and back pain. Neutropenia is a well-recognized adverse effect, in which the number of your white blood cells get reduced and your immune system gets weakened. As a result, you may be at greater risk of getting an infection. However, this side effect disappears rapidly once you stop taking the medicine.

Before using this medicine, let your doctor know if you have any preexisting medical conditions. Let your doctor also know about all the medications you are taking. Additionally, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

How to Use Kryxana Ribociclib Tablets

Kryxana Ribociclib Tablets are taken orally, once daily, exactly as prescribed by your oncologist. This medication should be consumed at the same time each day, with or without food, and never in greater or lesser amounts than directed. For the best therapeutic results, do not skip doses or discontinue without medical advice.

Therapeutic Benefits and Indications

Ribociclib serves as a targeted treatment option for postmenopausal women with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. As a CDK4/6 inhibitor, it disrupts cancer cell growth when used in combination with hormone therapies, increasing survival chances and potentially slowing disease progression.

Precautions and Monitoring During Treatment

Before and during treatment with Kryxana, routine monitoring of liver function and blood cell counts is essential to minimize risks and address any adverse reactions promptly. The medication is not suitable during pregnancy or lactation, unless strictly recommended by a physician. Always inform your healthcare provider of any other medications or supplements being taken.

FAQ's of 200mg Kryxana Ribociclib Tablets:

Q: How should Kryxana Ribociclib Tablets be taken for best results?

A: Kryxana Ribociclib Tablets are best taken orally, once daily at the same time as directed by your physician, with or without food. Never change your dose or schedule without consulting your doctor.

Q: What are the primary benefits of using Kryxana Ribociclib in breast cancer treatment?

A: Kryxana Ribociclib, when combined with other therapies, helps slow the progression of HR+/HER2- advanced or metastatic breast cancer by selectively inhibiting cancer cell division, thereby potentially improving survival outcomes.

Q: When is it necessary to monitor patients taking Kryxana Ribociclib?

A: Patients must have their liver function and complete blood counts monitored regularly before and during treatment to detect early signs of side effects such as neutropenia or liver impairment.

Q: What should I do if I miss a dose of Kryxana Ribociclib?

A: If you miss a dose, take it as soon as you remember on the same day. If it's almost time for your next dose, skip the missed dose. Do not take two doses at once.

Q: Where should Kryxana Ribociclib Tablets be stored to maintain their effectiveness?

A: Kryxana must be stored below 30C, protected from moisture and light, and kept in its original packaging to ensure potency throughout its 24-month shelf life.

Q: What common side effects should I expect while taking this medication?

A: Common side effects include fatigue, nausea, neutropenia, alopecia, leukopenia, anemia, and rash. Any persistent or severe symptoms should be reported to your doctor.

Q: Who is the recommended patient group for Kryxana Ribociclib?

A: Kryxana Ribociclib is recommended for adult women, especially postmenopausal, with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, as prescribed by a healthcare professional.

Tell us about your requirement